A carregar...
Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome
BACKGROUND: Dysregulated hedgehog signaling is the pivotal molecular abnormality underlying basal-cell carcinomas. Vismodegib is a new orally administered hedgehog-pathway inhibitor that produces objective responses in locally advanced and metastatic basal-cell carcinomas. METHODS: We tested the ant...
Na minha lista:
| Publicado no: | N Engl J Med |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4362529/ https://ncbi.nlm.nih.gov/pubmed/22670904 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1113538 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|